K.A.R. 100-22-8. Phosphatidylcholine and sodium deoxycholate.*(a) Except as specified in subsection (b), a person licensed to practice medicine and surgery or osteopathic medicine and surgery shall not administer or authorize the administration of phosphatidylcholine or sodium deoxycholate, or any combination of these substances, by subcutaneous injection for the purpose of eliminating or reducing localized fat accumulation.
          (b) This regulation shall not apply to clinical research on the administration of phosphatidylcholine or sodium deoxycholate, or any combination of these substances, as an investigational new drug.
          (c) Each departure from this regulation shall constitute prima facie evidence of dishonorable conduct. (Authorized by K.S.A. 65-2865; implementing K.S.A. 65-2836; effective, T-100-4-24-07, April 24, 2007; effective Sept. 14, 2007.)

*The Honorable David E. Bruns issued an order temporarily allowing a licensed M.D. or D.O. who properly performs a physical examination of the patient and records the patient’s medical history to issue a written prescription order to compound the mixture in accordance with the appropriate standard of care. The Board will conduct further hearings on this regulation, and notice of those hearings will be published in the Kansas Register.